Related Experiment Video

Updated: Jun 3, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Susceptibility of clinical Staphylococcus aureus isolates to innate defense antimicrobial peptides

Siegbert Rieg1, Achim J Kaasch, Julian Wehrle

  • 1Center for Infectious Diseases and Travel Medicine, Department of Medicine, University Hospital, Hugstetter Strasse 55, D-79106 Freiburg, Germany. siegbert.rieg@uniklinik-freiburg.de

Microbes and Infection
|April 9, 2011
PubMed

Insights

Antimicrobial peptides (AMPs) are key to innate immunity. This study found that Staphylococcus aureus (S. aureus) susceptibility to AMPs does not significantly differ between invasive infections and colonization, suggesting AMP resistance isn't a primary driver of invasive disease.

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Antimicrobial peptides (AMPs) are crucial components of the innate immune system.
  • Staphylococcus aureus (S. aureus) can cause both superficial and invasive infections.
  • Understanding factors that influence S. aureus virulence is critical for developing effective treatments.

Purpose of the Study:

  • To investigate if the susceptibility of S. aureus to AMPs differs based on infection type.
  • To compare AMP susceptibility between S. aureus isolates from bacteremia, skin infections, and colonization.

Main Methods:

  • Microbroth dilution assays were used to determine the minimum inhibitory concentrations (MICs) of specific AMPs.
  • Colony-forming unit (CFU) assays were employed to assess the bactericidal activity of AMPs.
  • 102 S. aureus isolates from various clinical sources were analyzed.

Main Results:

  • A narrow range of MICs was observed for human β-defensin-3, cathelicidin LL-37, and bovine indolicidin across all S. aureus isolate groups.
  • No significant differences in AMP susceptibility were found between isolates from invasive infections and colonizing isolates.
  • CFU assays showed only minor, non-significant differences in bactericidal activity.

Conclusions:

  • Differential in vitro antimicrobial peptide susceptibility does not appear to be a major determinant in S. aureus invasive infections.
  • These findings suggest that other factors likely play a more significant role in the transition from S. aureus colonization to invasive disease.

More Related Videos

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes12:27

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes

Published on: January 3, 2020

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds06:36

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds

Published on: September 8, 2021

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...